TELA Bio Inc. (TELA): Enterprise Value to EBITDA Ratio
TELA Bio, Inc. (TELA) maintains stable liquidity, with regular revenues from bio-implant sales fully covering operating expenses. Biomimetic-based OviTex innovative solutions are transforming hernia treatment methods, becoming a benchmark in surgery. The stock price retrospective on GURU.Markets, where the EV/EBITDA ratio is 0.00, accounts for risks associated with GPO dependency and a potential reduction in government procurement due to product costs.
Comprehensive metric breakdowns and analytics for telabio.com (TELA)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
TELA - Net Financial Result|Projected Future Earnings TELA Bio, Inc.|TELA - Price to Earnings Ratio|Forward P/E Multiple TELA Bio|TELA - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TELA Bio, Inc.|TELA - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months TELA Bio|TELA - Earnings per share for the trailing year|Quarterly EPS earnings growth telabio.com|TELA - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year TELA Bio, Inc.
Analysis of all company metrics:TELA Bio Corp TELA
The multiple compares the total enterprise value of TELA Bio, Inc. (TELA) including debt obligations, against its EBITDA, determining the asset payback period and the fundamental value of the business. The EV/EBITDA multiple trend reflects the scaling efficiency of OviTex matrix sales and margin growth, allowing investors to assess the fairness of the market share price relative to the company's actual operational efficiency.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio profoundmedical.com PROF|EV/EBITDA Multiple BDMD (Baird Medical)|EV/EBITDA Multiple EDAP TMS SA EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (pulmonx.com) - Enterprise Value to EBITDA Ratio|CytoSorbents Corporation - Business Value to Operating Income Before Depreciation|SRTS (Sensus Healthcare, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA zynex.com ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore, Inc. (ECOR)|vicarioussurgical.com (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple SeaStar Medical Holding Corp. ICU|IRIDEX Corp. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM (BioSig Technologies, Inc.) - Enterprise Value to EBITDA Ratio|CUTR: Enterprise Value to Operating Income Before Depreciation Ratio|KNW (Know Labs) - EV/EBITDA Multiple|Company Value to EBITDA Inari Medical Inc NARI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nevro Corporation (NVRO)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RSLS (reshapelifesciences.com)|EV/EBITDA Multiple SILK (Silk Road Medical, Inc)
